AU · biotech · infectious disease · respiratory
One round we have observed, with the investors the report named. Every figure below came from a named source, and where the company reported the raise to the SEC itself, that is shown beside it.
Series B · Oct 2025 · $34 million
Brandon Capital lead, Uniseed lead, Gates Foundation, Flu Lab, Stoic Venture Capital
Reported by Startup Daily
Missing a round, or an investor who was in one? Tell us.